Search - tctmd.com

Displaying 141 - 160 of 500

Sort: Relevancy | Date

Presentation

Net Clinical Benefit of Antithrombotic Therapy in Patients With A-fib and Chronic Kidney Disease

Presenter: Nissen Bonde

December 08, 2014

Presentation

Randomized Comparison of Renal Denervation vs Intensified Pharmacotherapy Including Spironolactone in True-Resistant Hypertension

Presenter: J?n Rosa

December 04, 2014

Presentation Cardiovascular Interventions 2014

Show Me The Data: Key Clinical Trials in 2014

Presenter: David P. Faxon

October 23, 2014

Presentation VEINS 2014

Renal, Mesenteric, and Aortic Duplex

Presenter: Heather L. Gornik

October 09, 2014

Presentation TCT 2014

Thoughtful Insights

Presenter: Krishna J. Rocha-Singh

September 17, 2014

Presentation TCT 2014

Case Presentation

Presenter: Justin E. Davies

September 17, 2014

Presentation TCT 2014

Noninvasive Renal Denervation Using Externally Delivered Focused Ultrasound: Early Experience Using Doppler-Based Imaging Tracking and Targeting for Treatment

Presenter: Michael Joner, Horst Sievert, Steven L. Almany, John A. Ormiston

September 16, 2014

Presentation TCT 2014

What Is the Clinical Trial Pathway Moving Forward for Renal Denervation?

Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka

September 16, 2014

Presentation TCT 2014

Global Perspectives in the Post-HTN-3 Era: A Kinder and Gentler Interpretation of Renal Denervation Therapy

Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka, Felix Mahfoud

September 16, 2014

Presentation TCT 2014

New Insights from SYMPLICITY HTN-3 What I Learned and What I Would Have Done Differently

Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka, Deepak L. Bhatt

September 16, 2014

Presentation TCT 2014

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Graham A. Cassel

September 16, 2014

Presentation TCT 2014

Access Site and the Risk of Acute Kidney Injury

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Hitinder S. Gurm

September 16, 2014

Presentation TCT 2014

Clinical Trial Updates: RenalGuard, AVERT, etc.

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon

September 16, 2014

$Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension$

Presentation TCT 2014

Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, Steffen Desch

September 16, 2014

Presentation TCT 2014

CON Problematic and Challenged

Presenter: Deepak L. Bhatt

September 16, 2014

Presentation TCT 2014

PRO Continued Optimism

Presenter: Felix Mahfoud

September 16, 2014

Presentation TCT 2014

Unfavourable Anatomy Of Renal Arteries Should Not Be An Exclusion Criteria For Renal Sympathetic Denervation

Presenter: Alexander Plehn

September 16, 2014

Presentation TCT 2014

Second generation devices for renal denervation give better renal blood flow when compared with 1st generation catheters

Presenter: Waleed Kadro

September 16, 2014

Presentation TCT 2014

First Clinical Experience with Neurotropic Agents for Treatment of Sympathetic Hypertension

Presenter: Horst Sievert

September 16, 2014

Presentation TCT 2014

CATHETER-BASED RENAL SYMPATHETIC DENERVATION FOR RESISTANT HYPERTENSION: A META-ANALYSIS OF RANDOMIZED TRIALS

Presenter: Daniel Garcia

September 16, 2014

Advertisement

Net Clinical Benefit of Antithrombotic Therapy in Patients With A-fib and Chronic Kidney Disease

Randomized Comparison of Renal Denervation vs Intensified Pharmacotherapy Including Spironolactone in True-Resistant Hypertension

Show Me The Data: Key Clinical Trials in 2014

Renal, Mesenteric, and Aortic Duplex

Thoughtful Insights

Case Presentation

Noninvasive Renal Denervation Using Externally Delivered Focused Ultrasound: Early Experience Using Doppler-Based Imaging Tracking and Targeting for Treatment

What Is the Clinical Trial Pathway Moving Forward for Renal Denervation?

Global Perspectives in the Post-HTN-3 Era: A Kinder and Gentler Interpretation of Renal Denervation Therapy

New Insights from SYMPLICITY HTN-3 What I Learned and What I Would Have Done Differently

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Access Site and the Risk of Acute Kidney Injury

Clinical Trial Updates: RenalGuard, AVERT, etc.

Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension

CON Problematic and Challenged

PRO Continued Optimism

Unfavourable Anatomy Of Renal Arteries Should Not Be An Exclusion Criteria For Renal Sympathetic Denervation

Second generation devices for renal denervation give better renal blood flow when compared with 1st generation catheters

First Clinical Experience with Neurotropic Agents for Treatment of Sympathetic Hypertension

CATHETER-BASED RENAL SYMPATHETIC DENERVATION FOR RESISTANT HYPERTENSION: A META-ANALYSIS OF RANDOMIZED TRIALS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content